CHD1L and cancer: For instance, higher levels of CHD1L, HDAC1, MUTYH, NEIL3, POLR2L, RUVBL1, and SPP1 expression in cancer cells have been linked to higher levels of drug resistance to nelarabine, acridine, chlorambucil, dexrazoxane, cladribine, and other drugs.